Useful Contacts

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2007
Volume 31
Issue 9

Useful Contacts

Useful Contacts

Indian Drug Manufacturers' Association (IDMA)

Mumbai

www.idma-assn.org,

tel. +91 22 2494 4624

Indian Pharmaceutical Association (IPA)

Mumbai

www.ipapharma.org,

tel: +91 22 2667 0742

Indian Pharma Machinery Manufacturers' Association (IPMMA)

Mumbai

www.ipmma.org,

tel: +91 22 2578 6007

Organization of Pharmaceutical Producers of India (OPPI)

Mumbai,

www.indiaoppi.com

Pharmaceuticals Export Promotion Council (Pharmexcil)

Hyderabad

www.pharmexcil.com,

tel: +91 40 2373 5462

For further information about the above companies, please email info@ecreviews.com or log on to ecreviews.com.

Articles in this issue
i4-455291-1408664386293.jpg
Advances in Asymmetric Synthesis
i1-455290-1408664389819.jpg
A Call for FDA Inspections
i1-455288-1408664393262.jpg
CMOs Join Pharma Facility Swap Meet
Supplements to the PQRI Workshop Results
i1-454947-1408664807148.jpg
How to Gain Approval Overseas
Pharma Capsules
i1-455287-1408664395306.jpg
Printing Digital Labels
i3_t-455286-1408664397850.jpg
Enhancing Drug Safety
i17_t-454945-1408664815843.gif
Lubrication of Direct-Compressible Blends with Magnesium Stearate Monohydrate and Dihydrate
i1-454948-1408664805478.jpg
The Challenges and Opportunities in ICH Q10
i1-452988-1408666904821.jpg
Case Studies
Revolution in Progress
ICH-Q10: A Recipe for the Product Life Cycle
ICH-Q10: A Recipe for the Product Life Cycle
i4-452935-1408667004344.jpg
Profiles in Biotechnology, Standards, Machinery, Innovation, Global Know-how, Strategies, and Expansion
Useful Contacts
Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Feliza Mirasol
November 19th 2024
Article

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment

Feliza Mirasol
November 16th 2024
Article

Frontier Scientific Solutions has unveiled plans to use a $1.5 billion commitment from a major investor to create a global free trade zone gateway to facilitate the life sciences supply chain using Wilmington International Airport in North Carolina.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Newly Opened Innovation Center in New Jersey Gives Avantor Advantage in Solving Life Sciences Challenges

Feliza Mirasol
November 15th 2024
Article

Avantor's newly launched expanded Innovation Center in Bridgewater, NJ, is designed for integrated workflows and features purpose-built collaboration spaces.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Avantor Sees Future of Opportunities with Growing Development of Next-Gen Biotherapeutics

Feliza Mirasol
November 15th 2024
Article

Executives at Avantor talk about the future of the biopharmaceutical industry and the anticipated impact that a wave of next-generation biotherapeutics will bring.